Chronic conditions
of national annual healthcare dollars are spent on chronic conditions with available preventative interventions.1
Genomic-informed health screening that is easy to integrate into health system workflows, enhancing patient care while also delivering value to the system as a whole.
of national annual healthcare dollars are spent on chronic conditions with available preventative interventions.1
per year, plus $168 billion in lost productivity. Cardiovascular costs are projected to hit roughly $2 trillion by 2050.2
1.7 million people are diagnosed with cancer each year in the United States and more than 600,000 die from it — the second leading cause of death.1
1. CDC, Chronic Disease. 2. Highmark, Cost of Chronic Health Conditions.
MyOme's advanced technology sequences the entire genome for a comprehensive view of a patient's health risks. Our proactive and diagnostic tests, with actionable insights, support early disease detection, prevention, and cost-effective treatment options. MyOme's testing platform helps identify high risk patients in need of enhanced screening or immediate care, creating value for patients and healthcare systems.
This is the future of every major healthcare system. Right now, when you go into any patient chart, you have self-reported allergies. And underneath their name in the upper left corner, depending on what EMR you're using, those are subjectively reported, very rarely objectively reported, risks for complications to the system.
Independent provider review and materials for helping patients understand complex concepts.
Access to genetic counseling to understand results and discuss preventive strategies.
HIPAA compliant, data encrypted at all times, systems updated to the latest security standards.
Contact us to find out how MyOme can seamlessly integrate with and bring value to your system.